a systematic review, only 37 cases of chylothorax secondary to PTB have been reported in literature.
Division of Respiratory and Critical Care
Medicine, National University Hospital, Singapore, Singapore Background and Aims: A 64-year old male, never smoker was hospitalized for increasing dyspnea due to a right malignant pleural effusion. CT thorax performed 3 weeks ago at another hospital reported a right upper lobe nodule with pleural effusion and ascites. He underwent thoracoscopic pleural biopsy, and talc poudrage. Repeat CT showed a spiculated right upper lobe nodule, mediastinal lymphadenopathy, pericardial effusion, ascites, peritoneal nodules and splenic nodules presumed to be metastatic disease. However, the pleural biopsy revealed acid-fast bacillus (AFB), caseating granulomas with Langhans' giant cells coexisting with adenocarcinoma stained TTF-1 positive (see image of pleural biopsy sample histology, showing necrotizing granulomatous inflammation (arrowhead) coexisting with adenocarcinoma cells (arrow) and acid fast bacillus (circle)). A transthoracic echocardiogram showed effusive-constrictive pericarditis supported by signs of distended jugular venous pressure and bilateral leg enema consistent with right heart failure. The patient underwent pericardial window creation as well as abdominal paracentesis. Pericardium, pericardial fluid and abdominal fluid were negative for malignancy, but cultures from peritoneal fluid and pericardium were positive for mycobacterium tuberculosis complex sensitive to first line anti-tuberculosis drugs. He was treated for TB with resolution of splenic and peritoneal disease and ascites. Persahabatan Hospital, Indonesia Background and Aims: Background: Drug-resistant tuberculosis is a problem of tuberculosis eradication program in Indonesia. Resistance pattern of Mycobacterium tuberculosis become important to understand. The aim of this study is to know the pattern of tuberculosis drug resistance based on patients characteristics and the type of drug resistance.
Methods:
Method: This is a descriptive analysis using baseline data from ongoing TB cohort study on drug resistance (TRIPOD). This study started to enrol the subjects on February 2017. Of 88 tuberculosis patients, 48 (54%) patients were drug resistance tuberculosis. Method: This is a descriptive analysis using baseline data from ongoing TB cohort study on drug resistance (TRIPOD). This study started to enrol the subjects on February 2017. Of 88 tuberculosis patients, 48 (54%) patients were drug resistance tuberculosis. Method: This is a descriptive analysis using baseline data from ongoing TB cohort study on drug resistance (TRIPOD). This study started to enrol the subjects on February 2017. Of 88 tuberculosis patients, 48 (54%) patients were drug resistance tuberculosis.
